Abstract:Purpose Sirtuin7 (SIRT7), as a member of the sirtuin and NAD + -dependent protein-modifying enzyme family, plays an important role in regulating cellular metabolism, stress responses, tumorigenesis, and aging. Ubiquitination and deubiquitination are reversible post-translational modifications that regulate protein stability, enzyme activity, protein–protein interactions, and cellular signaling transduction. However, whether SIRT7 is regulated by deubiquitination signaling is unclear. This study aims to elucidate the molecular mechanism of SIRT7 via deubiquitination signaling. Methods USP17L2 or SIRT7-targeting shRNAs were used to deplete USP17L2 or SIRT7. Western blot was applied to assess the effects of USP17L2 or SIRT7 depletion. A co-immunoprecipitation assay was used to detect the interaction relationship. Cell Counting Kit-8 assays were applied to assess the viability of breast cancer cells. An immunohistochemistry assay was employed to detect the protein level in samples from breast cancer patients, and the TCGA database was applied to analyze the survival rate of breast cancer patients. Statistical analyses were performed with the Student’s t test (two-tailed unpaired) and χ 2 test. Results We find that the deubiquitinase USP17L2 interacts with and deubiquitinates SIRT7, thereby increasing SIRT7 protein stability. In addition, USP17L2 regulates DNA damage repair through SIRT7. Furthermore, SIRT7 polyubiquitination is increased by knocking down of USP17L2, which leads to cancer cells sensitizing to chemotherapy. In breast cancer patient samples, high expression of USP17L2 is correlated with increased levels of SIRT7 protein. In conclusion, our study demonstrates that the USP17L2-SIRT7 axis is the new regulator in DNA damage response and chemo-response, suggesting that USP17L2 may be a prognostic factor and a potential therapeutic target in breast cancer. Conclusion Our results highlighted that USP17L2 regulates the chemoresistance of breast cancer cells in a SIRT7-dependent manner. Moreover, the role of USP17L2 as a potential therapeutic target in breast cancer and a prognostic factor for patients was elucidated.

SIRT7 is a Histone Desuccinylase That Functionally Links to Chromatin Compaction and Genome Stability

SIRT7 Is an RNA-Activated Protein Lysine Deacylase.

The Current Progress of Histone Deacetylase SIRT7

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

SIRT7 Facilitates CENP-A Nucleosome Assembly and Suppresses Intestinal Tumorigenesis

Function and Mechanism of Sir2 Gene Family

SIRT6 Coordinates with CHD4 to Promote Chromatin Relaxation and DNA Repair.

SIRT6 mono-ADP ribosylates KDM2A to locally increase H3K36me2 at DNA damage sites to inhibit transcription and promote repair

Structural basis of SIRT7 nucleosome engagement and substrate specificity

A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7.

Unraveling the multifaceted role of SIRT7 and its therapeutic potential in human diseases

Structural Insights into the Molecular Mechanism Underlying Sirt5-catalyzed Desuccinylation of Histone Peptides

Sirt7 Inhibits Sirt1-mediated Activation of Suv39h1

SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair

SIRT1 Deacetylates TopBP1 and Modulates Intra-S-phase Checkpoint and DNA Replication Origin Firing.

SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer

Synergy Between SIRT1 and SIRT6 Helps Recognize DNA Breaks and Potentiates the DNA Damage Response and Repair in Humans and Mice

A Click Chemistry Approach to Reveal the Chromatin‐dependent Histone H3 K36 Deacetylase Nature of SIRT7

A synergistic action of sirtuins directly recognizes DNA breaks and potentiates DNA damage response and repair

A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes.

Regulation of SIRT1 activity by genotoxic stress.